| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF4967-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-14350-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76542-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61823-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61705-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-55060-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76542 | |||
| BSA Free | NBP1-76542-0.025mg | |||
![Western Blot: BCL9-2 Antibody [NBP2-14350] - Analysis in human cell lines A-549 and HEK293 using anti-BCL9L antibody. Corresponding BCL9L RNA-seq data are presented for the same cell lines. Loading control: anti-HDAC1.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Western-Blot-NBP2-14350-img0010.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: BCL9-2 Antibody [NBP2-14350] - Analysis in human cell lines A-549 and HEK293 using anti-BCL9L antibody. Corresponding BCL9L RNA-seq data are presented for the same cell lines. Loading control: anti-HDAC1.")
![<b>Orthogonal Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: BCL9-2 Antibody [NBP2-14350] - Staining of human cell line CACO-2 shows localization to nucleoplasm. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-14350-img0005.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human liver shows no positivity in hepatocytes as expected.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0016.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human breast shows moderate to strong nuclear positivity in glandular cells.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0012.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human testis shows moderate nuclear positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0013.jpg)
![Immunohistochemistry-Paraffin: BCL9-2 Antibody [NBP2-14350] - Staining of human placenta shows moderate to strong nuclear positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-Paraffin-NBP2-14350-img0015.jpg)
![Western Blot: BCL9-2 Antibody [NBP1-76542] - HeLa cell lysate at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Western-Blot-NBP1-76542-img0004.jpg "Western Blot: BCL9-2 Antibody [NBP1-76542] - HeLa cell lysate at 1 ug/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: BCL9-2 Antibody - BSA Free [NBP1-76542] - Immunofluorescence of BCL9-2 in human breast tissue with BCL9-2 antibody at 20 ug/ml.Green: BCL9-2 Antibody Blue: DAPI staining](http://images.novusbio.com/fullsize/nbp1-76542_rabbit-polyclonal-bcl9-2-antibody-2711202420405548.gif)
![Immunohistochemistry: BCL9-2 Antibody [NBP1-76542] - Staining of Bcl9L in human breast tissue with Bcl9L antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunohistochemistry-NBP1-76542-img0006.jpg)
![Immunocytochemistry/ Immunofluorescence: BCL9-2 Antibody - BSA Free [NBP1-76542] - Immunocytochemistry of BCL9-2 in HeLa cells with BCL9-2 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76542_rabbit-polyclonal-bcl9-2-antibody-27112024204564.jpg)
![Western Blot: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Analysis using BCL9L mAb against human BCL9L (AA: 606-751) recombinant protein. (Expected MW is 41.9 kDa)](http://images.novusbio.com/fullsize/BCL9-2-Antibody-3B9C1-Western-Blot-NBP2-61823-img0003.jpg "Western Blot: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Analysis using BCL9L mAb against human BCL9L (AA: 606-751) recombinant protein. (Expected MW is 41.9 kDa)")
![Immunohistochemistry: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Analysis of paraffin-embedded cervical cancer tissues using BCL9L mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-3B9C1-Immunohistochemistry-NBP2-61823-img0002.jpg)
![Western Blot: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Analysis using BCL9L mAb against HEK293 (1) and BCL9L (AA: 606-751)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-3B9C1-Western-Blot-NBP2-61823-img0004.jpg)
![ELISA: BCL9-2 Antibody (3B9C1) [NBP2-61823] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/BCL9-2-Antibody-3B9C1-ELISA-NBP2-61823-img0001.jpg)
![Western Blot: BCL9-2 Antibody (1C9G2) [NBP2-61705] - Analysis using BCL9L mAb against human BCL9L (AA: 606-751) recombinant protein. (Expected MW is 41.9 kDa)](http://images.novusbio.com/fullsize/BCL9-2-Antibody-1C9G2-Western-Blot-NBP2-61705-img0003.jpg "Western Blot: BCL9-2 Antibody (1C9G2) [NBP2-61705] - Analysis using BCL9L mAb against human BCL9L (AA: 606-751) recombinant protein. (Expected MW is 41.9 kDa)")
![Flow Cytometry: BCL9-2 Antibody (1C9G2) [NBP2-61705] - Analysis of Hela cells using BCL9L mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/BCL9-2-Antibody-1C9G2-Flow-Cytometry-NBP2-61705-img0002.jpg)
![Western Blot: BCL9-2 Antibody (1C9G2) [NBP2-61705] - Analysis using BCL9L mAb against HEK293 (1) and BCL9L (AA: 606-751)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-1C9G2-Western-Blot-NBP2-61705-img0004.jpg)
![ELISA: BCL9-2 Antibody (1C9G2) [NBP2-61705] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/BCL9-2-Antibody-1C9G2-ELISA-NBP2-61705-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: BCL9-2 Antibody [NBP2-55060] - Staining of human cell line MCF7 shows localization to nucleoplasm & nucleoli.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-55060-img0001.jpg "Immunocytochemistry/Immunofluorescence: BCL9-2 Antibody [NBP2-55060] - Staining of human cell line MCF7 shows localization to nucleoplasm & nucleoli.")
![Western Blot: BCL9-2 Antibody [NBP1-71907] - Whole cell lysate from HeLa (15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded) and 293T (T; 50 mcg) cells. Affinity purified rabbit anti-BCL9L antibody used for WB at 0.1 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 6 mcg/mg lysate. BCL9L was also immunoprecipitated by another rabbit anti-BCL9L antibody, which recognizes an upstream epitope.](http://images.novusbio.com/fullsize/BCL9-2-Antibody-Western-Blot-NBP1-71907-img0002.jpg "<b>Independent Antibodies Validation and Biological Strategies Validation.</b>Western Blot: BCL9-2 Antibody [NBP1-71907] - Whole cell lysate from HeLa (15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded) and 293T (T; 50 mcg) cells. Affinity purified rabbit anti-BCL9L antibody used for WB at 0.1 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 6 mcg/mg lysate. BCL9L was also immunoprecipitated by another rabbit anti-BCL9L antibody, which recognizes an upstream epitope.")
![Western Blot: BCL9L Overexpression Lysate (Adult Normal) [NBP2-04846] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for BCL9L.](http://images.novusbio.com/fullsize/BCL9L-Overexpression-Lysate-Adult-Normal-Western-Blot-NBP2-04846-img0001.jpg "Western Blot: BCL9L Overexpression Lysate (Adult Normal) [NBP2-04846] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for BCL9L.")